The cumulative health and economic consequences of the premature loss of a parent may be greater for boys than for girls, suggest the findings of a large long term study published online in the Journal of Epidemiology & Community Health.
AstraZeneca snaps up Amolyt for $1.05bn to boost rare disease pipeline – Pharmaceutical Technology
Share this article AstraZeneca’s rare disease portfolio generated $7.76bn in global sales in 2023, as per the company’s Q4 financials. Image Credit: EllaSt / Shutterstock.